1.
Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B. Biomol Biomed [Internet]. 2023 May 1 [cited 2024 Dec. 6];23(3):527–534. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8260